QDEL.NASDAQQuidelortho CORP

Form 4: QuidelOrtho Director Ann D. Rhoads Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Ann D. Rhoads acquired restricted stock units in QuidelOrtho Corp in lieu of cash payments for board service-related fees.

Summary

  • On May 22, 2024, Ann D. Rhoads, a director of QuidelOrtho Corp, acquired restricted stock units (RSUs).
  • These RSUs were received in lieu of cash payments for retainer and Board of Director service-related fees under a deferred compensation program.
  • Rhoads acquired 4,929 RSUs that vest on May 22, 2025.
  • Additionally, 1,173 RSUs were converted, with 293 shares vesting on May 22, 2024, and subsequent vesting dates in August, November, and February.
  • A further 234 RSUs were received as a premium.
  • Following these transactions, Rhoads directly owns 4,929 restricted stock units, 1,173 converted restricted stock units, and 234 premium restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock unit acquisition by a director, indicating alignment with company performance but not necessarily a strong positive or negative signal.

Positives

  • The acquisition of RSUs by a director can be seen as a positive sign, indicating confidence in the company's future performance.
  • The deferred compensation program allows directors to align their interests with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs indicate a continued relationship between the director and the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates that a director is receiving equity compensation, which is a common practice in the industry.

Comparison to Industry Standards

  • Equity compensation for board members is a common practice across the industry.
  • Companies like Abbott, Roche, and Danaher also utilize stock options and restricted stock units as part of their compensation packages for directors.
  • The vesting schedules and amounts of equity grants vary depending on the company's size, performance, and compensation policies.

Related Party Transactions

  • The receipt of restricted stock units in lieu of cash payments for board service-related fees constitutes a related party transaction.

Stakeholder Impact

  • The acquisition of RSUs by a director can positively influence shareholder sentiment by demonstrating confidence in the company's future.

Key Dates

DateDescription
05/22/2024Date of transaction: Acquisition of restricted stock units, conversion of restricted stock units, and acquisition of premium restricted stock units.
05/22/2024Vesting date for 293 shares of converted restricted stock units.
08/22/2024Vesting date for 293 shares of converted restricted stock units.
11/22/2024Vesting date for 293 shares of converted restricted stock units.
02/22/2025Vesting date for 294 shares of converted restricted stock units.
05/22/2025Vesting date for 4,929 restricted stock units.
05/23/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.